Furthermore, Ammous et al. (2022) identified a significant correlation between hypomethylation at four CpGs, annotating to aryl hydrocarbon receptor repressor (AHRR, cg05575921 and cg21161138), TIMP metallopeptidase inhibitor 3 (GF11, cg09936388), and leucine rich repeat containing 52 (LRRC52, cg181168448), and atherosclerosis risk in an African American population. Here, LRRC52 is linked to atherosclerosis.